Target intelligence / Profile preview

Major capsid protein L1 (Human papillomavirus type 16) (HPV16 L1)

Target
HPV16 L1
Molecular classification
Viral protein, Capsid protein, Other
01

Overview

The major capsid protein L1 of Human papillomavirus type 16 (HPV16) is the primary structural component of the viral outer shell, which self-assembles into icosahedral capsids composed of 72 pentamers. This protein plays a critical role in the viral life cycle by binding to heparan sulfate proteoglycans on the surface of host basal layer keratinocytes, initiating viral attachment and subsequent endocytosis into host cells. HPV16 is a high-risk oncogenic virus strongly associated with the development of cervical, anal, vulvar, vaginal, penile, and oropharyngeal cancers. The L1 protein is the primary target for prophylactic HPV vaccines, such as Gardasil, Gardasil 9, and Cervarix, which utilize recombinant L1-based virus-like particles (VLPs) to elicit high titers of neutralizing antibodies. These antibodies block viral entry and prevent infection, although these vaccines do not exhibit therapeutic efficacy against pre-existing HPV infections.

Other names
Human papillomavirus type 16 major capsid protein L1HPV16 L1 capsid proteinL1 major capsid proteinLate major capsid protein L1VL1_HPV16
02

Mechanism of action

Active immunization via recombinant virus-like particles (VLPs) to induce high titers of neutralizing antibodies that block viral attachment and entry into host cells.

03

Biological functions

Viral attachment to host cellEndocytosis involved in viral entry into host cellHost-virus interactionOther
04

Disease associations

InfectionCancerOther
05

Safety considerations

Injection site reactions (pain, swelling, erythema)Systemic symptoms (fever, headache, fatigue, myalgia)SyncopeHypersensitivity/allergic reactionsLack of therapeutic efficacy against pre-existing HPV infections
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Anti-HPV16 L1 antibody titerHPV16 DNAp16INK4a expressionHPV L1 capsid protein expression

Beyond the preview

Go deeper on Major capsid protein L1 (Human papillomavirus type 16) (HPV16 L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major capsid protein L1 (Human papillomavirus type 16) (HPV16 L1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call